Skip to content

Chest ultrasonographic evaluation after intrapleural Alteplase versus Streptokinase injection in Children with Empyema

Chest ultrasonographic evaluation after intrapleural Alteplase versus Streptokinase injection in Children with Empyema

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202306656398595
Enrollment
75
Registered
2023-06-12
Start date
2023-03-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Paediatrics

Interventions

intrapleural Alteplase or Streptokinase injection in Children with Empyema or conservative approach
intrapleural streptokinase injection

Sponsors

Assiut University Children Hospital.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age: from1 month to18 years. Gender: both sexes will be included in the study. Empyema or CPPE along with evidence of septated pleural effusion on chest ultrasonography. All patients will undergo chest tube insertion along with intravenous antibiotics.

Exclusion criteria

Exclusion criteria: Age below 1 month. Patients with chronic empyema which is characterized by thickened visceral and parietal peels which hamper the ability of affected lung to re-expand and required definitive surgical intervention. Patients with bleeding tendency, recent trauma, recent operation and on anticoagulation. Children with pleural empyema from tuberculosis or malignancy. Children with allergy to tPA or streptokinase. Children with minimal parapneumonic effusion that do not require chest tube insertion. Presence of bronchopleural fistula or pyopneumothorax.

Design outcomes

Primary

MeasureTime frame
Primary outcome is assessment of the benefit and possible complications of intrapleural injection of tissue plasminogen activator and streptokinase in children with CPPE or empyema.

Secondary

MeasureTime frame
To compare between intrapleural injection of tissue plasminogen activator versus streptokinase in children with CPPE or empyema in reducing the need of further surgical intervention.

Countries

Egypt

Contacts

Public ContactMohamed Sayed

Lecturer

mohamed000@aun.edu.eg01153999115

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026